FDA NDC Directory · JSON-LD · Markdown

Ruconest

NDC 71274-350 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Generic namec1 esterase inhibitor recombinant
Labeler / ManufacturerPharming Healthcare Inc.
Marketing categoryBiologic License Application · App BLA125495
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAVENOUS
Active ingredientsCONESTAT ALFA (2100 U/1)
Marketing started20180401
Package count1

External sources

Source: openFDA. Public-domain (CC0).